AAAAAA

   
Results: 1-8 |
Results: 8
SUSTAINED PLATELET GP IIB IIIA BLOCKADE WITH ORAL ORBOFIBAN - INTERIMSAFETY AND TOLERABILITY RESULTS OF THE SOAR STUDY/
Authors: DEEDWANIA PC FERGUSON JJ KEREIAKES DJ FITZGERALD D ANDERS RJ BURNS DM BRYZINSKI BS
Citation: Pc. Deedwania et al., SUSTAINED PLATELET GP IIB IIIA BLOCKADE WITH ORAL ORBOFIBAN - INTERIMSAFETY AND TOLERABILITY RESULTS OF THE SOAR STUDY/, Journal of the American College of Cardiology, 31(2), 1998, pp. 94-94
SUSTAINED PLATELET GP IIB IIIA BLOCKADE WITH ORAL ORBOFIBAN - INTERIMPHARMACODYNAMIC RESULTS OF THE SOAR STUDY/
Authors: FERGUSON JJ DEEDWANIA PC KEREIAKES DJ FITZGERALD D ANDERS RJ BURNS DM BRYZINSKI BS
Citation: Jj. Ferguson et al., SUSTAINED PLATELET GP IIB IIIA BLOCKADE WITH ORAL ORBOFIBAN - INTERIMPHARMACODYNAMIC RESULTS OF THE SOAR STUDY/, Journal of the American College of Cardiology, 31(2), 1998, pp. 185-185
SAFETY AND EFFICACY OF PROLONGED PLATELET GP IIB IIIA BLOCKADE WITH XEMILOFIBAN - FINAL RESULTS OF THE ORBIT TRIAL/
Authors: KEREIAKES DJ KLEIMAN NS FERGUSON JJ ANDERS RJ HANTSBARGER GL BORTON MA ANDERSON LC WOHLFORD LL BRODERICK TM BRYZINSKI BS
Citation: Dj. Kereiakes et al., SAFETY AND EFFICACY OF PROLONGED PLATELET GP IIB IIIA BLOCKADE WITH XEMILOFIBAN - FINAL RESULTS OF THE ORBIT TRIAL/, Circulation, 96(8), 1997, pp. 2159-2159
A PLACEBO-CONTROLLED MULTICENTER COMPARISON OF A PHYSIOLOGICAL PATTERN RELEASE FORMULATION OF VERAPAMIL TO AMLODIPINE AND AMLODIPINE PLUS ATENOLOL IN PATIENTS WITH CHRONIC STABLE ANGINA-PECTORIS
Authors: FRISHMAN WH STONE PH GLASSER SP BRYZINSKI BS FAKOUHI TD
Citation: Wh. Frishman et al., A PLACEBO-CONTROLLED MULTICENTER COMPARISON OF A PHYSIOLOGICAL PATTERN RELEASE FORMULATION OF VERAPAMIL TO AMLODIPINE AND AMLODIPINE PLUS ATENOLOL IN PATIENTS WITH CHRONIC STABLE ANGINA-PECTORIS, Circulation, 96(8), 1997, pp. 2605-2605
FIRST-LINE THERAPY OPTION WITH LOW-DOSE BISOPROLOL FUMARATE AND LOW-DOSE HYDROCHLOROTHIAZIDE IN PATIENTS WITH STAGE-I AND STAGE-II SYSTEMICHYPERTENSION
Authors: FRISHMAN WH BURRIS JF MROCZEK WJ WEIR MR ALEMAYEHU D SIMON JS CHEN SY BRYZINSKI BS
Citation: Wh. Frishman et al., FIRST-LINE THERAPY OPTION WITH LOW-DOSE BISOPROLOL FUMARATE AND LOW-DOSE HYDROCHLOROTHIAZIDE IN PATIENTS WITH STAGE-I AND STAGE-II SYSTEMICHYPERTENSION, Journal of clinical pharmacology, 35(2), 1995, pp. 182-188
A MULTIFACTORIAL TRIAL DESIGN TO ASSESS COMBINATION THERAPY IN HYPERTENSION (VOL 154, PG 1461, 1994)
Authors: FRISHMAN WH BRYZINSKI BS COULSON LR DEQUATTRO VL VLACHAKIS ND MROCZEK WJ DUKART G GOLDBERG JD
Citation: Wh. Frishman et al., A MULTIFACTORIAL TRIAL DESIGN TO ASSESS COMBINATION THERAPY IN HYPERTENSION (VOL 154, PG 1461, 1994), Archives of internal medicine, 155(7), 1995, pp. 709-709
BISOPROLOL, A ONCE-A-DAY BETA-BLOCKING AGENT FOR PATIENTS WITH MILD-TO-MODERATE HYPERTENSION
Authors: DAVIDOV ME SINGH SP VLACHAKIS ND BLUMENTHAL JB SIMON JS BRYZINSKI BS KOURY KJ ALEMAYEHU D
Citation: Me. Davidov et al., BISOPROLOL, A ONCE-A-DAY BETA-BLOCKING AGENT FOR PATIENTS WITH MILD-TO-MODERATE HYPERTENSION, Clinical cardiology, 17(5), 1994, pp. 263-268
A MULTIFACTORIAL TRIAL DESIGN TO ASSESS COMBINATION THERAPY IN HYPERTENSION - TREATMENT WITH BISOPROLOL AND HYDROCHLOROTHIAZIDE
Authors: FRISHMAN WH BRYZINSKI BS COULSON LR DEQUATTRO VL VLACHAKIS ND MROCZEK WJ DUKART G GOLDBERG JD ALEMAYEHU D KOURY K
Citation: Wh. Frishman et al., A MULTIFACTORIAL TRIAL DESIGN TO ASSESS COMBINATION THERAPY IN HYPERTENSION - TREATMENT WITH BISOPROLOL AND HYDROCHLOROTHIAZIDE, Archives of internal medicine, 154(13), 1994, pp. 1461-1468
Risultati: 1-8 |